Found 5 matching trials
Safety and Efficacy of Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduction of the Latent HIV-1 Reservoir
PHASE1The REDUC trial's objective is to address one of the core issues with the t...
Location
Aarhus University Hospital, Skejby Sygehus
Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV
PHASE2Current management of HIV infection includes anti-retroviral therapy (ART)....
Re-boosting of HIV-1 Infected Subjects With Vacc-4x
PHASE2During the course of HIV infection the number of CD4 cells decreases, resul...
Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART)
PHASE1During the course of HIV infection the number of CD4 cells decreases, resul...
Location
University Medical Center Hamburg-Eppendorf
Intranasal Modified Vacc-4x Gag Peptides With Endocine as Adjuvant
PHASE1HIV-specific cellular immunity is hampered in most HIV-infected individuals...
Location
Department of Infectious Diseases, Oslo University Hospital